Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1351-1360 of 2870 for cancer

Edit search filters
  1. A Study for Cerebral Open Flow Microperfusion

    Rochester, MN

  2. A Study To Compare Stereotactic Radiosurgery To Hippocampal-Avoidant Whole Brain Radiotherapy

    Jacksonville, FL, Rochester, MN

  3. S0820, Adenoma and Second Primary Prevention Trial

    Rochester, MN

  4. Study To Determine The Impact Of Advanced Magnetic Resonance Imaging (MRI) Using 18F-DOPA (A Chemical Tracer That Highlights Certain Cells During Imaging) During Planning For Proton Beam Radiation Therapy.

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Apixaban In Preventing Secondary Cancer Related Blood Clots In Cancer Patients Who Have Completed Anticoagulation Therapy

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, Rochester, MN

  6. Treatment Of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. FT819 In Subjects With B-cell Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. FT516 In Subjects With Advanced Hematologic Malignancies

    Scottsdale/Phoenix, AZ

  9. Blood-Brain Barrier Disruption (BBBD) For Liquid Biopsy In Subjects With GlioBlastoma Brain Tumors

    Rochester, MN

  10. A Phase 1 Dose Escalation And Expansion Study Of TGR-1202 + Ruxolitinib In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, Or Polycythemia Vera Resistant To Hydroxyurea

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer